The Japanese Respiratory Society (2018) The JRS Guidelines for the Management of Drug-induced lung disease (2nd edition). Medical Review, Tokyo (Article in Japanese)

Skeoch S, Weatherley N, Swift AJ et al (2018) Drug-induced interstitial lung disease: a systematic review. J Clin Med 7:356. https://doi.org/10.3390/jcm7100563

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spagnolo P, Bonniaud P, Rossi G et al (2022) Drug-induced interstitial lung disease. Eur Respir J 60:2102776. https://doi.org/10.1183/13993003.02776-2021

Article  CAS  PubMed  Google Scholar 

Schwaiblmair M, Behr W, Haeckel T et al (2012) Drug-induced interstitial lung disease. Open Respir Med J 6:63–74

Article  PubMed  PubMed Central  Google Scholar 

Iwasa E, Fujiyoshi Y, Kubota Y et al (2020) Interstitial lung disease as an adverse drug reaction in Japan: exploration of regulatory actions as a basis for high reporting. Drug Saf 43:1121–1131

Article  PubMed  PubMed Central  Google Scholar 

Matsumoto K, Nakao S, Hasegawa S et al (2020) Analysis of drug-induced interstitial lung disease using the Japanese adverse drug event report database. SAGE Open Med 8:1–13

Article  Google Scholar 

Enomoto Y, Nakamura Y, Enomoto N et al (2017) Japanese herbal medicine-induced pneumonitis: a review of 73 patients. Respir Investig 55:138–144. https://doi.org/10.1016/j.resinv.2016.11.007

Article  PubMed  Google Scholar 

Sachs B, Fatangare A, Sickmann A et al (2021) Lymphocyte transformation test: history and current approaches. J Immunol Methods 493:113036. https://doi.org/10.1016/j.jim.2021.113036

Article  CAS  PubMed  Google Scholar 

Matsuno O (2012) Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res 13:39. https://doi.org/10.1186/1465-9921-13-39

Article  PubMed  PubMed Central  Google Scholar 

Fujimori T, Kasagawa T, Ishii N et al (2019) Occult breast carcinoma and recurrent tumor in the breast 14 years after axillary dissection – a case report. Gan To Kagaku Ryoho 46:2249–2251

PubMed  Google Scholar 

Hirohashi Y, Kawashima Y, Shimonishi T et al (2020) A case of recurrent breast cancer with drug-induced interstitial pneumonia triggered by the switch from an original to a generic aromatase inhibitor. Gan To Kagaku Ryoho 47:1707–1709

PubMed  Google Scholar 

Horiuchi K, Suzuki R, Kawamata A et al (2011) Bronchiolitis obliterans organizing pneumonia caused by endocrine therapy after breast-conserving surgery: report of 2 cases diagnosed by drug lymphocyte stimulation test (DLST). Nihon Rinsho Geka Gakkai Zasshi 72:613–618

Article  Google Scholar 

Mueller-Mang C, Ringl H, Herold C (2017) Multislice CT. Springer, Heidelberg

Google Scholar 

Vasiljevic D, Arnold C, Neuman D et al (2018) Occurrence of pneumonitis following radiotherapy of breast cancer – a prospective study. Strahlenther Onkol 194:520–532

Article  PubMed  PubMed Central  Google Scholar 

Eggert MC, Yu NY, Rades D (2023) Radiation dermatitis and pneumonitis in patients irradiated for breast cancer. In Vivo 37:2654–2661. https://doi.org/10.21873/invivo.13374

Article  PubMed  PubMed Central  Google Scholar 

Rahi MS, Parekh J, Pednekar P et al (2021) Radiation-induced lung injury-current perspectives and management. Clin Pract 11:410–429

Article  PubMed  PubMed Central  Google Scholar 

Rattay B, Benndorf RA (2021) Drug-induced idiosyncratic agranulocytosis - infrequent but dangerous. Front Pharmacol 12:727717. https://doi.org/10.3389/fphar.2021.727717

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrès E, Mourot-Cottet R, Maloisel F et al (2017) Idiosyncratic drug-induced neutropenia and agranulocytosis. QJM 110:299–305

PubMed  Google Scholar 

Lorenzo-Villalba N, Alonso-Ortiz MB, Maouche Y et al (2020) Idiosyncratic drug-induced neutropenia and agranulocytosis in elderly patients. J Clin Med 9:1808. https://doi.org/10.3390/jcm9061808

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtis BR (2017) Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. Hematology Am Soc Hematol Educ Program 2017:187–193. https://doi.org/10.1182/asheducation-2017.1.187

Article  PubMed  PubMed Central  Google Scholar 

Herrscher H, Leblanc J, Petit T (2020) Agranulocytosis induced by tamoxifen in a breast cancer patient. Breast Care 15:72–74

Article  PubMed  Google Scholar 

Al-Bairmany YSA (2022) Leucopenia induced by tamoxifen in a breast cancer patient: a case report. Ann Cancer Res Ther 30:8–10

Article  Google Scholar 

Ching CK, Smith PG, Long RG (1992) Tamoxifen-associated hepatocellular damage and agranulocytosis. Lancet 339:940. https://doi.org/10.1016/0140-6736(92)90991-b

Article  CAS  PubMed  Google Scholar 

Miké V, Currie VE, Gee TS (1994) Fatal neutropenia associated with long-term tamoxifen therapy. Lancet 344:541–542. https://doi.org/10.1016/S0140-6736(94)91929-1

Article  PubMed  Google Scholar 

International Adjuvant Therapy Organisation (1985) Myelosuppression occurring after receiving tamoxifen for breast cancer. Br J Radiol 58:1220. https://doi.org/10.1259/0007-1285-58-696-1220

Article  Google Scholar